| INTRODUCTION
Diagnostic complexities exist across the spectra of histopathology with recent studies of this phenomenon focusing on breast and cutaneous lesions. [1] [2] [3] [4] [5] [6] Collectively, these studies indicate that for both breast and cutaneous lesions, distinguishing between atypia and in situ disease is especially challenging. [1] [2] [3] [4] [5] [6] Although these studies indicate these intricacies exist, less discussed is that misclassifications can result in both under-and over-diagnosis, affecting subsequent treatment regimens across the entire diagnostic range, 7, 8 and more information is needed about how interventions might be developed to address such complexities. Most pathologists who are uncertain of a complex diagnosis will obtain a second opinion, 4 and now more than 60% of pathology laboratories in the United States have policies to guide the use of second opinions. 9 In a recent cross-sectional study involving pathologists, 10 survey respondents reported that the use of second opinions improves their own diagnostic accuracy. This suggests the learning curve for expertise development expands beyond residency and into independent practice.
Some human malignancies have similar morphologic traits, 11 a phenomenon that is fairly common in surgical pathology. Known as morphologic mimicry, one such cluster includes ductal carcinomas of cutaneous appendages, breasts and salivary glands. 11 In 1 study of 103 tumors in this structural cluster, striking homologies among these tumors were found that were typified by irregular permeative clusters and cords of atypical polygonal cells with varying luminal differentiation. 11 While most of the literature on diagnostic agreement of histopathology includes studies within one tissue type, we hypothesized that much could be learned by studying levels of diagnostic agreement across different tissue types when interpretations were compared with a reference diagnosis obtained by a panel of experienced pathologists with expertise in their respective tissues.
We conducted an observational study that involved enrolled pathologists who interpret skin and breast biopsies, all of whom interpreted sets of cases representing a relevant spectrum of diagnostic categories in their respective fields. More specifically, we designed 2 web-hosted self-paced continuing medical education interventions, one focused on melanocytic skin biopsy interpretations and the other focused on breast biopsy interpretations of ductal epithelial proliferations. Each intervention allowed participants to compare their interpretations to a reference diagnosis developed by a consensus panel.
Prior to seeing their how their interpretations compared to the reference diagnoses but after interpreting the test sets, we asked participants to estimate the extent to which their interpretations would agree with the reference diagnosis so we could explore differences between perceived and actual performance preintervention. After the intervention, we asked pathologists to recall how their interpretations compared to the reference diagnosis to determine differences between perceived and actual performance postintervention. Here, we present the results from these interventions and discuss how findings from this study may help unite pathologists toward coming to a common understanding of interpretations of difficult or borderline cases. All participants were enrolled in 1 of 2 nation-wide studies on diagnostic variability, one focused on melanocytic cutaneous lesions 12 and the other focused on interpretation of breast biopsy interpretations. 3 Pathologists who interpret skin biopsies were recruited using publicly available information from 10 US states (CA, CT, HI, IA, KY, LA, NJ, NM, UT and WA). Pathologists who interpret breast biopsies were recruited using the same approach from 8 geographically diverse states (AK, ME, MN, NM, NH, OR, WA and VT). More specifically, eligible pathologists were invited to participate via email, with telephone and street mail used for follow-up of initial nonresponders. Eligibility criteria included interpreting cutaneous melanocytic or breast biopsies as part of current practice, having signed out biopsies for at least 1 year prior to enrollment, and intention to continue interpreting biopsies for at least 1 year after enrollment.
All participating physicians completed a brief 10-minute survey that assessed their demographic characteristics (age, sex), training and clinical experiences (fellowship, case load, interpretive volume, years interpreting, academic affiliations), and perceptions of how challenging their respective pathology types are to interpret. This survey was administered prior to beginning test set interpretations. Two hundred and seven pathologists were enrolled in the skin biopsy specimen study ( Figure 1) , and of these 187 completed all pre-educational intervention study activities and were therefore eligible to participate in the educational intervention (90.3%), of whom 158 completed it (84.5%). A full description of the overall pool of pathologists who interpreted skin lesions is described elsewhere, 12 but those participating in the intervention portion of the study represented 52.5% of pathologists (158/301) whose eligibility we could determine from the 10 states.
One hundred and twenty-six pathologists who interpret breast biopsy specimens agreed to take part in the study and were eligible to undertake the educational intervention according to completion of all pre-intervention study activities. Of these, 94 completed the intervention (74.6%), with 92 providing complete information (73.0%) ( Figure 1) . A full description of the overall pool of pathologists who interpreted breast tissue is described elsewhere, 3 but those participating in the intervention portion of the study represented 37.3% of pathologists (94/252) whose eligibility we could determine from the 8 states. Four pathologists who completed the intervention portion of the breast interpretation study also participated in the skin pathology study, which occurred approximately 2 years later.
| Test set development
Detailed information on the development of the test sets is published elsewhere for cutaneous melanocytic lesions 5 and breast specimens. 13 Briefly, cutaneous test set cases were identified from a large dermatopathology laboratory in the Pacific Northwest, 5 and breast test set cases were identified from biopsy specimens obtained from mammography registries with linkages to breast pathology and/or tumor registries in Vermont and New Hampshire. 14, 15 A consensus process was undertaken by 3 experienced dermatopathologists and 3 experienced breast pathologists to come to a consensus reference diagnosis for each case in the test sets, which is described in detail elsewhere. 5 
| Educational intervention development and implementation
The educational intervention was designed to provide a researchbased review of differences among pathologists in cutaneous melanocytic and breast lesion interpretation. It was a self-paced Internethosted program individualized to participant's performance on their respective test sets. Figure 2 illustrates activities related to the educational intervention.
| Pre-intervention assessments
At the start of the program (before participants reviewed how their interpretations compared to the reference diagnosis), we asked them to compare how similar the test set cases were to cases they see in actual clinical practice (response options ranged from "I never see cases like these" to "I always see cases like these"), and we asked them to indicate the number of continuing medical education (CME) hours they had undertaken in cutaneous melanocytic or breast or lesions as well as their CME preferences (instructor led, self-directed or other).
Additionally, we asked participants to estimate the proportion of their diagnoses on test cases they thought would agree with the consensus reference diagnoses overall and within each of the 4 or 5 diagnostic categories reviewed. These estimates are referred to as the "preintervention perceived agreement."
| Operational features of the intervention
The educational intervention then proceeded to show the pathologists, on a case-by-case basis, how their independent interpretations actually compared with the consensus reference diagnosis according to diagnostic classification. By clicking on the case number, participants could view a digital whole slide image of the case on their computer screens and could scan and magnify the image as with a conventional microscope. Case-specific microscopic diagnostic comments, developed by experienced pathologists on the respective consensus reference panels, were provided for each case. Participants could review the cases and comments for as long as they desired and were given the opportunity to share their own thoughts on each case after reviewing their results and reading the experienced pathologists' microscopic diagnostic comments. 
| Postintervention assessments
After the intervention, a survey asked study participants to re-rate how their interpretations compared to the consensus reference diagnosis, so we could assess the extent to which they recognized, processed and recalled the difference between their perceived and actual agreement with the consensus panel as a result of the intervention.
These estimates are referred to as "post-intervention perceived agreement." We then asked them to complete required knowledge questions, so we could award CME credits. Completion of all study activities, including the test set interpretations and the educational intervention resulted in awarding up to 20 Category 1 CME hours.
| Data analyses
We used descriptive statistics to characterize the demographic and clinical training experience as well as ratings of the test sets and challenges involved in interpreting pathology. We stratified the pathologists who interpreted skin tissue according to their receipt of specialized training and/or board certification in dermatopathology.
Only 3 of the pathologists interpreting breast biopsies were fellowship trained in breast pathology, a number too small for stratification. Histograms were used to compare perceived differences in interpretive performance compared to actual performance, both overall as well as within each diagnostic category for both pre-and postintervention assessments. Among the 94 participants who completed the breast CME program, differences between perceived and actual performance rates could not be assigned for 2 participants (2.1%) due to missing responses. These 2 participants were excluded from analyses. Similarly, 4 (6.0%) of the 67 enrolled participants who completed the dermatopathology CME program had incomplete or missing responses and were excluded from analyses ( Figure 1 ). Categorical data are pre- To assess the effect participation in both educational interventions may have had on study results, we conducted a sensitivity analysis by removing data on the 4 pathologists who participated in both educational interventions from the intervention data for the skin educational intervention, because this intervention occurred second, about 2 years after the breast intervention. We found no differences in study findings when they were in or out of the skin intervention analyses, so these pathologists were included in the analyses of both interventions.
| RESULTS
The characteristics of the pathologists who interpret breast biopsy specimens were similar with regard to age, gender, affiliation with an academic medical center and years interpreting breast and/or melanocytic lesions to those who interpreted skin biopsy specimens (Table 1A,B) . Pathologists who interpret skin biopsies were more likely to be fellowship trained or board certified than those who interpret breast biopsies (3% for breast and 40% for dermatopathologists, P = <.001; Table 1A ). Pathologists interpreting skin tissue reported signing out more cases per month than those interpreting breast biopsies (28% having >150 cases per month vs 2%, P = <.001; Table 1A) , and 44% of skin pathologists vs 18% of breast pathologists perceived they were considered experts by their peers (P = <.001). Additionally, 87% of board-certified dermatopathologists were self-reported to be considered an expert by their peers. Ninety-five percent of skin pathologists reported finding pathological interpretation of tissue challenging vs 52% of breast pathologists (P = <.001). Similarly, 70%
of skin pathologists reported that interpreting melanocytic cutaneous lesions makes them more nervous than other types of pathology (with skin pathologists with additional certification/fellowship training in dermatopathology even more so at 76%), whereas 48% of breast pathologists reported that interpreting breast tissue makes them more f "Never or rarely see cases like these" and "never see cases like these" was provided to M-Path and B-Path participants, respectively, and are treated as equal responses; "almost always see cases like these" was not a response provided in B-Path study but was provided in M-Path study. Missing value not included in inferential statistics.
g Self-directed programs that are online and self-directed programs that are not online were possible responses in M-Path study and were combined to match the response provided in B-Path (self-directed responses). Missing value not included in inferential statistics.
h Total hours includes time spent filling out baseline survey in addition to the time spent reviewing slides during the 2 phases of the study and the CME website.
nervous that other types of tissue (P = <.001; Table 1B ). An equivalent amount of median time spent on the CME website was reported by skin pathologists and breast pathologists (2 hours vs 2 hours, P = .29) and median time spent by pathologists in both groups to interpret the initial slide set was also similar (8 hours vs 8 hours, P = .45).
The mean pre-intervention perceived agreement for all pathologists interpreting skin tissue was 72.9%, while the actual agreement FIGURE 3 Comparison of perceived vs actual agreement among all skin pathologists at the pre-intervation assessment (n = 63).
? From matched-pairs t test for the difference between the pair of means expressed as mean difference (95% confidence interval) FIGURE 4 Comparison of perceived vs actual agreement among fellowship-trained and/or board certified at the preintervation assessment (n = 63).
? from matched-pairs t test for the difference between the pair of means expressed as mean difference (95% confidence interval) from matched-pairs t test for the difference between the pair of means expressed as mean difference (95% confidence interval) FIGURE 7 Differences in perceived vs actual agreement among all skin pathologists as part of the educational intervention according to individual diagnostic categories (pre-and post-intervention) (n = 158).
? the proportion of participants whose difference in perceived vs actual agreement fell within plus-minus 5% of zero difference skin pathologists overestimated their perceived performance by 11.9% (95% CI 3.0%-20.8%) more on average than pathologists who were dermatopathology certified and/or fellowship trained prior to the educational intervention and by 8.9% (95% CI 2.6%-15.3%) post-educational intervention (data not shown). Overall mean perceived agreement for pathologists interpreting breast tissue (the extent they thought they would agree with the reference diagnosis) was 81.4% (all 4 categories combined), while the actual agreement was 75.9% ( Figure 6 ). Figure 7 illustrates the alignment among all skin pathologists for their 5 diagnostic categories pre-and postintervention. As shown, alignment among these pathologists was much lower for nevus, mild atypia (Class I), moderate atypia (Class II) and melanoma in situ (Class III) at about 60%. Figure 8 shows this alignment among dermatopathologists (those with fellowship training/board certification) pre-and postintervention. Those with additional training/credentialing were only slightly more aligned than this group of pathologists as a whole where nevus, mild atypia (Class I) and moderate atypia (Class II) aligned at about 66% to 68%, and melanoma in situ (Class III) was at about 60% and alignment for pT1a invasive melanoma and >pT1b were about 45%. Figure 9 illustrates this alignment among pathologists without fellowship training pre-and postintervention. Alignment was highest at about 66% for melanoma in situ and was lowest for invasive melanoma (both categories) at about 45% to 47%. and recalled what they learned about the extent of agreement with the reference diagnosis. In the first 3 panels where the reference diagnoses were benign without atypia, atypia, and DCIS, the alignment reached 82% to 88%, whereas the alignment for invasive reached 93%.
| DISCUSSION
This study is the first to our knowledge to explore how comparisons of pathologists interpreting lesions from 2 different organ systems, breast and skin, might differ and how these pathologists perceived their diagnoses would agree with a reference diagnosis determined by a consensus panel of experienced pathologists. Our intent was to examine what might be learned from comparing and contrasting these complex interpretive experiences rather than attempting to conform interpretive practices from each into one standardized approach, which should not be done. FIGURE 8 Differences in perceived vs actual agreement among fellowship-trained and/or board certified Dermatopathologists as part of the educational intervention according to individual diagnostic categories (pre-and post-intervention) (n = 63).
? the proportion of participants whose difference in perceived vs actual agreement fell within plus-minus 5% of zero difference
We learned that the magnitude of difference among pathologists interpreting skin lesions compared to those interpreting breast tissue perceptions of diagnostic agreement was approximately 4 times greater, indicating they perceived they would agree with the reference diagnosis much more often than they actually did. In addition, after undertaking the intervention and reviewing cases where they both agreed with and did not agree with the reference diagnosis and received case-specific microscopic diagnostic comments about each case, skin pathologists were less likely to process or recall alignment with the reference diagnosis compared to breast pathologists. Surprisingly, while 95% of those interpreting breast tissue were especially likely to align with the reference diagnosis at the end of the intervention for invasive cancer, both invasive categories for those interpreting skin tissue only aligned at about 45%, which was lower than benign or in situ cases.
There are a few reasons why this might have occurred. One is believe in the grading of dysplasia 16 while others aggressively dismiss the idea of dysplasia altogether. 17 These differences have resulted in a highly complex system of classification for melanocytic lesions with the development of local variations in terminology and criteria that make agreement across different centers more difficult to achieve, perhaps, than in breast cancer where there is more standardization.
Regardless of philosophical stance, dermatopathologists performance was more variable in our model. One key factor missing from all approaches to the melanocytic lesion is the difficulty of correlation Borderline cases generate disagreement and differences of opinion among pathologists. Our own research 12 has shown that accuracy using a consensus diagnosis of experienced pathologists as reference varied by class with agreement for nevus or mild atypia at 92% (95% CI 90%-94%); moderate atypia at 25% (22%-28%); severe atypia or melanoma in situ) at 40% (37%-44%); early invasive melanoma at 43%
(39%-46%) and invasive melanoma at 72% (69%-75% ? the proportion of participants whose difference in perceived vs actual agreement fell within plus-minus 5% of zero difference participation in high quality, unbiased learning and self-assessment activities relevant to specialty and areas of practice. 19 We endeavored to foster the development of unbiased consensus diagnoses in both these educational interventions, and they specifically included rigorous self-assessment directly related to clinical pathology. In addition, Part II MOCs are intended to be relevant, easy-to-use, cost-effective and meaningful for practicing physicians and, given our high rates of completion, we believe that we achieved these additional outcomes. The new MOC system is not without controversy 20 with many physicians raising concerns about expense, burden, and whether it is a clinically relevant process. What is needed in the new MOC system is evidence that patient care is better as a result, which is currently lacking. Our intervention was not directly associated with patient outcomes. This type of work must be done to provide this needed evidence.
Another relevant area for implications involves malpractice. We published 2 studies examining pathologists' perspectives on how concerns about medical malpractice may affect their interpretive practices. In both papers 21, 22 the majority of pathologists reported undertaking protective behaviors due to concerns about medical malpractice, including ordering additional stains, recommending additional surgical sampling, obtaining second reviews or choosing the more severe diagnosis for borderline cases. More research should be done in this area.
The strengths of this study include the representation by about a third of eligible breast pathologists and just over half of eligible dermatopathologists from several states in the United States. In addition, comparisons were made using 2 sets of cases with very carefully developed reference diagnoses for both breast and skin tissues. Weaknesses include that interpretations involved only one slide per case, which is not representative of actual clinical practice.
Additionally, the skin pathologists reviewed melanocytic skin cases rather than general skin cases. As a result, the skin cases included in the test sets were more difficult lesions to interpret. Another weakness is that pathologists in this study likely interpret both breast and skin tissue, and we do not know the extent that this is the case among participants. The educational interventions also included subtle wording differences, which could have affected perceptions of agreement. For example, in the breast CME, the reference panel was referred to as "the expert panel" and in the skin CME, the ref-
erence panel was referred to as "the consensus panel." We do not expect such differences would have affected the results to a great extent. Lastly, there were scale differences between the 2 studies in that the skin intervention used 5 diagnostic categories, while the breast intervention used 4. These differences were not addressed statistically, although participants in both interventions provided an estimate between 0% and 100%. However, the scale differences may have influenced the choices they made. Also, the summary rates of agreement are compared ignoring the denominator within and between M-Path (36 vs 48 cases) and B-Path studies (60 cases).
In conclusion, pathologists interpreting breast tissue appeared to experience higher comprehension of their performance of the intervention based on their alignment with the consensus diagnosis after the intervention compared to pathologists interpreting skin biopsies.
